Dario Blood Glucose Monitoring System - Android Devices User Performance Study Report
NCT ID: NCT02910674
Last Updated: 2021-04-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2016-07-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study
NCT02916563
User Performance Evaluation for DARIO™ BGMS
NCT02357043
Dario™ Blood Glucose Monitoring System - User Performance Evaluation
NCT02053584
Protocol for the Evaluation of Dario™ BGMS Performance at Elevated Altitude
NCT02352298
System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus
NCT02290067
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
One Arm
This is a comparative diagnostic study, no interventional actions are being taken.
Dario Blood Glucose Monitoring System
Accuracy with usability assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dario Blood Glucose Monitoring System
Accuracy with usability assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject speaks and reads English proficiently
* Subject is able and agrees to sign the informed consent form (minor subjects must be accompanied by a parent or legal guardian to provide consent for their participation in the study)
Exclusion Criteria
* Subject is critically ill.
* Subject has an impairment that prevents him/her from following the study procedures.
* Subject has any condition that the Principal Investigator believes may interfere in the subject's participation in the study.
* Hematocrit levels outside the range of 20%-60%.
13 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LabStyle Innovations Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barbara Davis Center
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-0004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.